Efficacy, Safety and Tolerability of BAF312 Compared to Placebo in Patients With Intracerebral Hemorrhage (ICH).
Status:
Completed
Trial end date:
2020-05-13
Target enrollment:
Participant gender:
Summary
This is a randomized, placebo-controlled, subject and investigator-blinded study to evaluate
efficacy, safety and tolerability of BAF312 in participants with intracerebral hemorrhage
(ICH)